Primary information |
---|
ID | 13597 |
Uniprot ID | Q9WUG6 |
Description | Insulin-like peptide INSL5 (Insulin-like peptide 5) (Relaxin/insulin-like factor 2) (Relaxin/insulin-like protein) [Cleaved into- Insulin-like peptide INSL5 B chain; Insulin-like peptide INSL5 A chain] |
Organism | Mus musculus |
Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Glires (Rodents and rabbits); Rodentia; Myomorpha (mice and others); Muroidea; Muridae; Murinae; Mus; Mus; Mus musculus (Mouse) |
Subcellular Location | Secreted |
Developmental Stage | NA |
Similarity | Belongs to the insulin family. |
Tissue Specificity | Highest expression in colon with lower levels in thymus. Minimal levels in testis. |
Post Translational Modification | NA |
Function | May have a role in gut contractility or in thymic development and regulation. Activates RXFP4 with high potency and appears to be the endogenous ligand for this receptor. |
Length | 135 |
Molecular Weight | 15 |
Name | Insulin-like peptide INSL5 B chain |
Sequence | QTVKLCGLDYVRTVIYICASSRW |
Sequence map | 23-46 |
PDB ID | NA |
Drugpedia | NA |
Receptor | NA |
Domain | NA |
Pharmaceutical Use | NA
|